doi: 10.1074/jbc.M802187200
5 Scientists are currently researching the possibility of using next-generation GLP-1 drugs to treat disorders of the central nervous system, such as Alzheimers disease, Parkinsons disease, and stroke, neuropsychiatric conditions, and cardiovascular disease
Orgainc Aloe Barbadensis Leaf Juice, Stinging Nettle Hydrosol, Glycerin, Hydrolized Hyaluronic Acid, Pentylene Glycol, Caffeine, Glyciene, Soy Peptide, Silica, L-Methionine, Pyridoxine, Glutamic Acid, Copper Peptide(GHK-cu), Vitamin B12, Melatonin, Biotin, Centella Asiatica Extract, Acetyl Hexapeptide-8, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-5, Allantoin, Pantothenic Acid, Hydrolyzed Keratin, Saw Palmetto, L-Arginine, Vitis Vinifera Fruit Cell Extract (Grape Stem Cell ), Myristoyl Pentapeptide-17, Ethyl Ascorbic Acid, Niacin, Zinc, Lactobacillus, Bourdock Extract, Catalase, Sodium Chloride, Disodium DHA, Methylsulfonylmethane, Propanedil, Lactic Acid, Ethylhexylglycerin
J Royal Statis Soc B
But when it comes to the newer drugs safety, we have to do our due diligence. Stay tuned